'Avodart' n'aka. ntụziaka

The agwọ ọrịa "Avodart" (analogues - pụtara "Duprost" "Dutasteride") na-ezo aka a ìgwè nke ọgwụ ọjọọ eme maka ọgwụgwọ nke hyperplasia na na prostate benign okike. Ọgwụgwọ na-inhibitors nke 5-Alfa reductase. The n'ọrụ mgwa - dutasteride.

The ọgwụ bụ "Avodart" ntuziaka na-atụ aro iji wepụ na gbochie progression nke benign prostatic hyperplasia, inyeaka mgbaàmà, belata size nke prostate. Ọgwụ mma urination, ebelata ihe ize ndụ nke na-emepe emepe nnukwu urinary igbu oge, na-egbochi mkpa n'ịwa ahụ. Medicine "Avodart" ike ga-eji na Nchikota na ihe Alfa 1-blockers ma ọ bụ dị ka monotherapy.

Ọgwụ contraindicated na onye ekweghị ibe nọrọ dutasteride na ndị ọzọ mmiri, nakwa dị ka ndị ọzọ inhibitors nke 5-Alfa reductase. Pụtara "Avodart" ntụziaka machibidoro ụmụ ndị inyom.

Ikweta na ọgwụ ike ga-metụtara ụfọdụ mmetụta. Mmetụta ọjọọ nke ego "Avodart" ntụziaka ndị gynecomastia (ụba na ịdị nro na-ara), ejaculation aghara, ebelata libido, enweghi ike.

Na obere okwu, nfụkasị Jeremaya nwere ike ime n'ụdị mmachi ọzịza, pruritus, ọkụ ọkụ, angioedema, urticaria.

The ọgwụ bụ "Avodart" nduzi na-atụ aro na, ọ dịkarịa ala ọnwa isii, na ọbụna ma ọ bụrụ na ọgwụgwọ mmetụta mere pụtara ngwa ngwa kemgbe mmalite nke ngwa. Ma ọ bụghị ya, nnọọ ike inye onye na ebumnobi nwale nke ọgwụ edinam.

The ọgwụ nwere ike iwere enweghị banyere nri.

The dose maka okenye ikom (na ndị agadi gụnyere) otu Capsule (500 mg) otu ugboro n'ụbọchị. ghara nro ma ọ bụ na-ata ọgwụ.

Ọ dịghị mkpa ka ịhazie onunu ogwu maka ọrịa nke na akụrụ ya.

Ịkpachara anya ga-agbasoriri mgbe na-ekenye na ọrịa na mkpọchị hepatic ọrụ, n'ihi na eziokwu na-arụsi ọrụ ike akụrụngwa na-ọtụtụ metabolized na imeju.

Na-adakarị omume, ikpe nke ọgwụ ovadozu bụghị kọwara. N'ihi na eziokwu na e nwere a kpọmkwem ngwọta na ikpe nke-enyo enyo na-anata ibu ọgwụ ọjọọ, "Avodart" symptomatic ma na-akwado ọgwụ.

Irè pụtara dutasteride akụrụngwa ike etinye obi gị dum n'ime anụ. Na nke a, ụmụ na ndị inyom kwesịrị izere kọntaktị na capsules, nke akwusila ike n'ezi ihe nke shei. Ọ bụrụ na mberede na kọntaktị ga-ozugbo gbarụrụ akpụkpọ.

Tupu ngwa nke ọgwụ "Avodart" ndị ikom na ọnụnọ nke benign prostatic hyperplasia dị mkpa na-ebu a rectal nnyocha nke prostate.

Identification nke prostate-kpọmkwem antigen ihe bụ akụkụ nke mgbagwoju research eme iji na nchọpụta nke cancer na prostate.

Mgbe ọnwa isii ọgwụgwọ na "Avodart" ọrịa kwuru a ọnụ ke ọbara prostate-kpọmkwem antigen site 50% ọbụna na ọnụnọ nke cancer na prostate. Mgbe abolition nke ọgwụ akụrụngwa na-laghachi na mbụ larịị n'ime ọnwa isii.

The ruru nke free na ngụkọta PSA ịta anaghị ịdị iche iche ọbụna n'oge ọgwụgwọ agwọ ọrịa "Avodart".

Mgbe nnyocha gosiri na Nchikota ọgwụ na Alfa-blockers dịkwuo ize ndụ nke obi ọdịda.

Agwọ ọrịa "Avodart" enweghị mmetụta na ike ụgbọala ugbo ala ma ọ bụ ime ihe ọ bụla ọzọ nwere ize ndụ ọrụ.